Anti-PEG scFv corona ameliorates accelerated blood clearance phenomenon of PEGylated nanomedicines
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-PEG scFv corona ameliorates accelerated blood clearance phenomenon of PEGylated nanomedicines
Authors
Keywords
scFv, Anti-PEG antibody, Accelerated blood clearance phenomenon, Complement activation, Nanomedicine
Journal
JOURNAL OF CONTROLLED RELEASE
Volume 330, Issue -, Pages 493-501
Publisher
Elsevier BV
Online
2020-12-29
DOI
10.1016/j.jconrel.2020.12.047
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Natural IgM dominates in vivo performance of liposomes
- (2020) Tianhao Ding et al. JOURNAL OF CONTROLLED RELEASE
- Premature Drug Release from Polyethylene Glycol (PEG)-Coated Liposomal Doxorubicin via Formation of the Membrane Attack Complex
- (2020) Even Chen et al. ACS Nano
- Hepatosplenic phagocytic cells indirectly contribute to anti-PEG IgM production in the accelerated blood clearance (ABC) phenomenon against PEGylated liposomes: Appearance of an unexplained mechanism in the ABC phenomenon
- (2020) Marwa Mohamed El Sayed et al. JOURNAL OF CONTROLLED RELEASE
- PEGylated liposomes: immunological responses
- (2019) Marwa Mohamed et al. SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS
- Survey of Clinical Translation of Cancer Nanomedicines—Lessons Learned from Successes and Failures
- (2019) Hongliang He et al. ACCOUNTS OF CHEMICAL RESEARCH
- Overcoming anti-PEG antibody mediated accelerated blood clearance of PEGylated liposomes by pre-infusion with high molecular weight free PEG
- (2019) Morgan D. McSweeney et al. JOURNAL OF CONTROLLED RELEASE
- A generic method for the detection of polyethylene glycol specific IgG and IgM antibodies in human serum
- (2019) Christopher Ehlinger et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Brain-targeted drug delivery by manipulating protein corona functions
- (2019) Zui Zhang et al. Nature Communications
- Engineering of single chain antibodies for solubility
- (2018) Yaghoub Safdari INTERNATIONAL IMMUNOPHARMACOLOGY
- Progress and challenges towards targeted delivery of cancer therapeutics
- (2018) Daniel Rosenblum et al. Nature Communications
- Enhanced immunocompatibility of ligand-targeted liposomes by attenuating natural IgM absorption
- (2018) Juan Guan et al. Nature Communications
- Effect of Kupffer cells depletion on ABC phenomenon induced by Kupffer cells-targeted liposomes
- (2018) Chaoyang Lai et al. Asian Journal of Pharmaceutical Sciences
- Theranostic Imaging May Vaccinate against the Therapeutic Benefit of Long Circulating PEGylated Liposomes and Change Cargo Pharmacokinetics
- (2018) Betina Børresen et al. ACS Nano
- Engineering Bifunctional Antibodies with Constant Region Fusion Architectures
- (2017) Juanjuan Du et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- A genome-wide association study identifies a novel susceptibility locus for the immunogenicity of polyethylene glycol
- (2017) Chia-Jung Chang et al. Nature Communications
- ZnO-Based Nanoplatforms for Labeling and Treatment of Mouse Tumors without Detectable Toxic Side Effects
- (2016) Dai-Xin Ye et al. ACS Nano
- PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
- (2016) Jung Soo Suk et al. ADVANCED DRUG DELIVERY REVIEWS
- Analysis of Pre-existing IgG and IgM Antibodies against Polyethylene Glycol (PEG) in the General Population
- (2016) Qi Yang et al. ANALYTICAL CHEMISTRY
- Measurement of Pre-Existing IgG and IgM Antibodies against Polyethylene Glycol in Healthy Individuals
- (2016) Bing-Mae Chen et al. ANALYTICAL CHEMISTRY
- Exploring the relationship between anti-PEG IgM behaviors and PEGylated nanoparticles and its significance for accelerated blood clearance
- (2016) Kouichi Shiraishi et al. JOURNAL OF CONTROLLED RELEASE
- Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation
- (2016) Peng Zhang et al. JOURNAL OF CONTROLLED RELEASE
- Anti-PEG IgM and complement system are required for the association of second doses of PEGylated liposomes with splenic marginal zone B cells
- (2015) Taro Shimizu et al. IMMUNOBIOLOGY
- Advanced therapeutic approach for the treatment of malignant pleural mesothelioma via the intrapleural administration of liposomal pemetrexed
- (2015) Hidenori Ando et al. JOURNAL OF CONTROLLED RELEASE
- Anti-PEG IgM Is a Major Contributor to the Accelerated Blood Clearance of Polyethylene Glycol-Conjugated Protein
- (2015) Yu Mima et al. MOLECULAR PHARMACEUTICS
- Lipids and Their Derivatives: By-Products Used as Essential Building Blocks for Modern Drug Delivery Systems
- (2014) Ying Tu et al. CURRENT DRUG TARGETS
- State-of-the-art in design rules for drug delivery platforms: Lessons learned from FDA-approved nanomedicines
- (2014) Charlene M. Dawidczyk et al. JOURNAL OF CONTROLLED RELEASE
- Anthracycline nano-delivery systems to overcome multiple drug resistance: A comprehensive review
- (2013) Ping Ma et al. Nano Today
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects
- (2010) Kazuo Maruyama ADVANCED DRUG DELIVERY REVIEWS
- PEG Branched Polymer for Functionalization of Nanomaterials with Ultralong Blood Circulation
- (2009) Giuseppe Prencipe et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now